Statistics

Total Visits

Views
The JAK inhibitor tofacitinib for active rheumatoid arthritis: Results from Phase III trials82

Select a period of time:

Number of views in the range

Views
The JAK inhibitor tofacitinib for active rheumatoid arthritis: Results from Phase III trials28

Views

Views
June 202515
July 20257
August 20251
September 20252
October 20251
November 20251
December 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
Brazil6
United States3
Argentina1
Egypt1
United Kingdom1
Guatemala1
 

Top cities views

Views
Arealva1
Dallas1
Giza1
Guatemala City1
Hull1
Itaperuna1
Missouri City1
Paracatu1
Piraquara1
Porto Alegre1